How Novartis Is Helping Staff Through COVID-19 Crisis
Initiatives To Cope For A World In Lockdown
Executive Summary
Speaking to Scrip, Steven Baert, chief people and organization officer at Novartis, said that a company’s response to coronavirus reveals its real identity and will shape its future.
You may also be interested in...
Novartis Oncology Head Discusses Cancer Care Challenge With COVID-19
Susanne Schaffert tells Scrip that policies of prioritizing coronavirus treatment to the detriment of cancer care was a worrying move that is negatively impacting survival and mortality.
Coronavirus Update: Novartis Targets COVID-19 Cytokine Storm With Jakavi
Novartis's Jakavi joins the likes of Roche's Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients.
Novartis CEO Backs Malaria Drug Against COVID-19
A coronavirus vaccine is some way off and until then, Vas Narasimhan, head of Novartis, is thinking that of the drugs being repurposed to treat COVID-19, hydroxychloroquine looks best placed to provide the quickest benefit.